Merck renews commitment to the education of tomorrow's scientific innovators
TERREBONNE, QC, April 10, 2014 /CNW/ - Merck is proud to once again be a partner of the Super Expo‑sciences Hydro-Québec provincial final, whose 2014 edition starts today at Cégep régional de Lanaudière à Terrebonne.
From April 10 to 13, le Cégep will welcome some 160 young students from across Québec. These students will be presenting the projects that made them stand out in their 12 respective regional finals.
"At Merck, we are committed to investing in our communities and in our future scientific innovators. As Medical Director, I am especially impressed by the participants' initiative to subscribe to this unique scientific competition", said Dr. Mauricio Ede, Medical Director, Medical Affairs, Merck Canada Inc. "I wish them luck and I'm looking forward to seeing what these young scientists will come up with."
The winners of the best projects at the Québec finals will make up the delegation representing Québec at the 53nd Canada-wide Science Fair 2014 being held from May 10 to 17 in Windsor, Ontario. Merck, as the main sponsor of the Québec delegation, is proud to support the 40‑member team who will participate in the 53nd Canada-Wide Science Fair.
At the Super Expo-sciences Hydro-Québec provincial final closing ceremony, Merck Canada will award a $1,000 "Exploring Minds" bursary for the best experimental or design project focused on the preservation and improvement of human health. At the 12 regional Science Fair finals leading up to the Québec provincial final, Merck awarded bursaries of $400 for experimental or design projects. The winners will join the "Exploring Minds" group, made up of all of Merck's past bursary recipients.
As a key part of its overall commitment to science, Merck supports young people who have an enthusiasm for research and scientific progress through various projects, such as the Science Fairs.
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information about our operations in Canada, visit www.merck.ca.
Forward Looking Statement
This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck's management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck's 2012 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).
SOURCE Merck Canada Inc.For further information: Media contact: Marie-Christine Garon, Merck, 514-428-3445; Joey Morabito, NATIONAL Public relations, 514-843-2399